We found that the magnitude of dysregulation of many major gene pathways in CRC were significantly higher in patients with the KRAS mutation; and the up- and down-regulation of those dysregulated gene pathways could be correlated with corresponding hypo- and hyper-methylation. Here, KRAS is linked to colorectal carcinoma.